• A Mirazimi.
• Department of Clinical Microbiology, Karolinska Institutet, Stockholm, Sweden.
• J. Intern. Med. 2015 Sep 1; 278 (3): 227237227-37.

AbstractEbola virus disease (EVD) is a zoonotic disease that causes severe haemorrhagic fever, with high fatality rates of up to 90% in humans. Today, there is no effective treatment available. Person-to-person transmission occurs through exposure to blood or body fluids, which can threaten other household members and first-line healthcare workers. The first cases of EVD in Guinea were identified on 22 March 2014. It was initially believed that this like previous outbreaks would be self-limiting. However, lack of public health infrastructure, delays in virus detection and late implementation of control interventions contributed to widespread transmission of EVD in a region inexperienced in dealing with the disease. Socio-cultural and economic factors probably also played a key role in the spread of the disease, resulting in the current large-scale outbreak. Some promising candidate treatments for this disease are now being developed.© 2015 The Association for the Publication of the Journal of Internal Medicine.

19 keywords...

hide…